The authors would like to correct the errors in Table 1 and text in the published article. The correct table and the text should read as below.
In Table 1 , the numbers for the intent-to-treat population for biliary stent and previous Whipple procedure were erroneously switched. Table 1 should appear as below.
The corresponding text for Table 1 under the Baseline Characteristics heading in the Results section should read, ''Fewer patients in the Canadian cohort had a KPS of 100 than in the ITT population,'' i.e., removing ''or previous Whipple procedure'' from the original sentence which read ''Fewer patients in the Canadian cohort had a KPS of 100 or previous Whipple procedure than in the ITT population.'' Under the Statistical Analyses section, the second-to-last sentence reads ''A nonstratified log-rank test was PFS between the treatment arms, and the HR and two-sided 95% CIs were estimated by a Cox proportional hazards model.'' It should read ''A stratified log-rank test was used to compare PFS between the treatment arms, and the HR and two-sided 
Variable
Patients in Canada ITT population [9] (N 5 861) nab-P 1 Gem (n 5 33) Gem (n 5 30)
Previous Whipple procedure, n (%) 3 (9) 2 (7) 62 (7) CA 19-9 carbohydrate antigen 19-9, Gem gemcitabine, ITT intent-to-treat, KPS Karnofsky performance status, nab-P nab-paclitaxel, ULN upper limit of normal a Total evaluable patients = 858 b Total evaluable patients = 750 c This value was not reported in Ref. [9] 
